Knee IKDC improvement
International Knee Documentation Committee score. A higher score means better knee function.
The CFI is a single in-clinic injection that lays a fresh layer of natural collagen over your worn joint, with no surgery and no general anaesthetic. London Cartilage Clinic was the first UK clinic to offer ChondroFiller® as an injection.
Treatment with Professor Paul YF Lee · 66 Harley Street, London
Watch: how ChondroFiller® works
How the collagen scaffold is placed into a cartilage defect and how your own cells migrate in to rebuild tissue over the following months. The mechanism is the same for the clinic injection and the surgical Liquid Cartilage™ keyhole procedure.
ChondroFiller® is a registered trademark of Meidrix Biomedicals GmbH.
ChondroFiller® is appropriate across the spectrum of cartilage wear, from a contained focal defect to diffuse surface wear across the whole joint. There is no upper age limit and no defect-size limit on the injection, and it is particularly valuable as a pre-replacement option for active patients in their 60s, 70s and beyond.
Find your pathway
Eight short questions, around two minutes. Get a personal pathway from a ChondroFiller Injection to a keyhole procedure or a combination plan, with a clear next step.
Suitability is confirmed by Professor Lee at consultation after imaging review. The suitability guide sets out the full assessment framework, including when another pathway may fit better.
Why this is different
ChondroFiller® was designed by its manufacturer, Meidrix Biomedicals GmbH, to fill a focal cartilage defect during keyhole surgery: a precise hole in the cartilage, packed under arthroscopic vision. At London Cartilage Clinic that keyhole use is our Liquid Cartilage™ (LCS) pathway.
The breakthrough on this page is different. The CFI (ChondroFiller Injection) uses the same collagen, but delivers it as a simple in-clinic injection that coats the worn surface of the joint, rather than filling a single discrete hole. There is no surgery and no general anaesthetic. It is a novel approach pioneered here, and it opens ChondroFiller up to broadly worn joints, not just contained focal defects.
Keyhole ChondroFiller is surgery, and it follows the manufacturer's surgical rehabilitation. The injection is an outpatient appointment, and you walk out the same hour. The recovery section below sets the two side by side.

A biological collagen scaffold delivered in liquid form. It gels in minutes, providing a 3D framework for your own cells to grow healthy, hyaline-like cartilage.
“ChondroFiller® injection is like resurfacing a road where the entire surface is worn but the structure underneath is intact. A fresh protective layer is laid across the whole stretch in a single pass. There is no upper age limit and no defect-size limit, because the procedure does the protective work itself.”

The procedure is short, but the regeneration plays out over months. Here is what happens at each stage.
MRI imaging reviewed at consultation to confirm the cartilage defect, its size, location and the surrounding cartilage. The number of ChondroFiller® boxes is decided here.
A 30 to 45 minute outpatient appointment, no general anaesthetic, no surgical incision. The acellular collagen gel is delivered precisely into the defect under real-time ultrasound guidance.
The collagen gel sets in situ within minutes, filling the defect and forming a three-dimensional matrix that protects the area and invites the body’s own cells in.
Over six to twelve months, the body’s own resident cells migrate into the scaffold and lay down hyaline-like cartilage. Improvement typically begins at six to twelve weeks, with continued benefit building over the year.
One treatment. One short appointment. A cartilage repair process that runs in the background for months.


A patient’s perspective
Hear Professor Lee on why he uses ChondroFiller, and watch a narrated visit featuring ChondroFiller, Mytocel and PRF.
You leave on your own feet. Your written aftercare sets the pace, and the team stays on hand while the scaffold does its work.

30 to 45 minutes under local anaesthetic and ultrasound guidance. You walk out the same hour, with no brace and no crutches unless your medical team specifies otherwise.
Keep things quiet. Light, necessary activity only, with ice through a cloth if the joint is sore.
Aim for about half your usual activity involving the joint.
Build duration, distance and intensity step by step. A free telephone review at six weeks checks your progress.
New tissue establishes within the scaffold. Most patients notice improvement from six to twelve weeks, with benefit building over the year.
Much of what you read online about ChondroFiller recovery describes the keyhole implant. That surgical route follows the manufacturer's rehabilitation guidance, used for our Liquid Cartilage™ pathway. None of it applies to the injection.
| Stage | ChondroFiller injection | Keyhole ChondroFiller |
|---|---|---|
| Setting | Outpatient clinic, local anaesthetic | Theatre, general or spinal anaesthetic |
| Brace | None | Joint held still in a brace for 48 hours |
| Weight-bearing | Walking from day one | Rebuilt gradually over about 6 to 8 weeks |
| High-load sport | Rebuilt in stages from week 3, as advised | Six months or later |
Expected outcomes
Headline outcomes from peer-reviewed ChondroFiller® studies across knee, hip and small joints, with more than 19,000 ChondroFiller® cases performed worldwide.
See the full evidence
Published results · selected patients with appropriate defects
International Knee Documentation Committee score. A higher score means better knee function.
Harris Hip Score after treatment. A higher score means better hip function.
Magnetic Resonance Observation of Cartilage Repair Tissue. A higher score means a more complete repair.
Individual outcomes vary by defect size, location and surrounding cartilage. The numbers come from selected patients with appropriate defects, not from everyone who has treatment.
Your own imaging, examination and goals decide whether ChondroFiller is a sensible option for you. Read the evidence and its limits →
Read the research yourself
Access peer-reviewed research on the safety and efficacy of ChondroFiller® across various joint pathologies. Each paper opens as a PDF.
Animal StudyPreclinical evaluation of ChondroFiller® in animal models.PDF download ↗
Behaviour of Human CartilageInsights into cartilage response and regeneration potential.PDF download ↗
Cartilage Reconstruction Using ChondroFiller® in Intra-Articular Distal Radius FracturesCase-based reconstruction of wrist joint cartilage defects.PDF download ↗
Cell-Free ApproachConcept and outcomes of scaffold-based, cell-free cartilage repair.PDF download ↗
Collagen Matrix for Cartilage RepairStructural collagen scaffolds and their role in joint preservation.PDF download ↗
Femoroacetabular ImpingementManaging hip impingement with structural cartilage regeneration.PDF download ↗
Hip DefectsTreatment of focal cartilage lesions in the hip joint.PDF download ↗
Needle and Curette TechniqueMinimal access technique for preparing cartilage defects.PDF download ↗
Osteoid OsteomaManaging osteoid osteoma with joint surface restoration.PDF download ↗
Regeneration of Cartilage DefectsOutcomes of defect-filling regenerative strategies.PDF download ↗
Safety of ChondroFiller®Safety data and complication profile from clinical use.PDF download ↗Download the ChondroFiller® leaflet: Professor Lee's guide to injectable cartilage regeneration at London Cartilage Clinic.
Download PDF

Supplier Information
Brochures from Actomed, the UK supplier of ChondroFiller®, covering patient information, the clinical technique, rehabilitation, and the thumb-arthritis (Rhizarthrosis) application.

General patient overview from Actomed, the UK supplier, covering what ChondroFiller is, who it suits and what to expect.

Supplier technique brochure for clinicians: defect preparation, scaffold placement and the regenerative pathway.

Supplier rehabilitation brochure for the arthroscopic implantation route, covering brace, partial weight-bearing and graded loading. It does not apply to the ultrasound-guided injection.

Supplier brochure on the thumb-base (CMC joint) application of ChondroFiller for Rhizarthrosis.

Short supplier overview of ChondroFiller in two pages, the quickest read in the set.
ChondroFiller® is a registered trademark of Meidrix Biomedicals GmbH. These materials are provided for patient and clinician reference only.
Eight things that distinguish ChondroFiller® here from a generic injection appointment.
The injection route for ChondroFiller is Professor Paul Lee’s own clinical development, delivered under ultrasound guidance. If you have come across the product elsewhere, the consultation and injection still happen here.
Meet Professor LeeRecognised by the International Cartilage Regeneration and Joint Preservation Society as a Teaching Centre. Cartilage regeneration is a principal interest; our published outcome database is among the largest in Europe.
See the evidenceEvery ChondroFiller injection is delivered under real-time ultrasound guidance, not by anatomical landmark alone. The product fills a specific defect; placement without imaging defeats the point.
Check your suitabilityEvery patient is assessed by Professor Lee in person. The clinician you see at consultation is the clinician who delivers the injection. No hand-off to a less experienced operator.
Who is suitable?Although the infection risk for a ChondroFiller® injection is low, we include IV antibiotic cover and sterile-field standards above the typical outpatient norm. Safety is layered, not optional. The same protocol is applied to our Arthrosamid® injections.
What is includedChondroFiller fits a treatment philosophy that prefers preserving and regenerating your own joint over replacement. The reason patients travel here for a second opinion before agreeing to knee or hip replacement elsewhere.
Our cartilage regeneration approachFixed box-tier pricing from £3,000, inclusive of ultrasound, the ChondroFiller product, the injection and the six-week follow-up. The consultation is charged separately.
See ChondroFiller costSix-week clinical review included as standard, with onward physiotherapy guidance and a direct line to the team during recovery. Aftercare is part of the treatment, not an add-on.
Free discovery callExplore your options
A structural scaffold sits differently from lubricating or symptom-relief injections, and from surgery. Each guide compares aims, evidence, recovery and cost.
Box-tier pricing, the same across all joints. Each tier includes ultrasound, the ChondroFiller product, the injection, IV antibiotic cover and the six-week follow-up. The number of boxes is confirmed at consultation.

We specialise in joint preservation. The clinician you see at consultation is the clinician who delivers your injection.
“Repair, not replace: that’s the future of joint care.”
The icing on the cake · Optional
Your ChondroFiller injection can be elevated with MSC (Medicinal Signalling Cells), your body's own repair cells. In early studies this combination has shown even greater improvement than the scaffold alone. It is an entirely optional enhancement, chosen by patients who want to give their joint every possible advantage.
Your own Medicinal Signalling Cells (MSC) are gently harvested during your appointment, from bone marrow, fat or platelet-rich fibrin. The source is chosen with you at consultation.
The cells are placed inside the ChondroFiller collagen scaffold. The scaffold holds them exactly where they are needed, so they stay put rather than dispersing.
Held in place, the cells add a biological signal that supports the cells doing the rebuilding, working alongside the scaffold to drive regeneration.
Cost, cover, suitability and recovery in brief. Need more help? Consult with Professor Paul Lee on Harley Street.
Book a consultationChondroFiller at London Cartilage Clinic costs from £3,000 for one box, £5,500 for two boxes, or £8,000 for three boxes. Each price is inclusive of ultrasound, the ChondroFiller product, the injection itself and a six-week clinical follow-up. The consultation is charged separately. The same pricing applies whether the defect is in the knee, hip, shoulder, ankle, elbow, foot, hand or wrist. See the ChondroFiller cost guide for full detail.
ChondroFiller is an acellular collagen scaffold that fills a cartilage defect and provides a framework for the body’s own cells to migrate in and regenerate hyaline-like cartilage. Published outcome data shows +30 IKDC in knees, +33 Harris Hip Score in hips, and MOCART MRI scores of 70 to 87 indicating high-quality cartilage regeneration, with over 19,000 global cases supporting safety. Outcomes depend on defect size, location, surrounding cartilage quality and patient suitability.
No. ChondroFiller is not routinely funded by the NHS and is not currently covered by the major UK private medical insurers, including Bupa and AXA. Patients access ChondroFiller privately on a self-funded basis at London Cartilage Clinic. We can provide an itemised invoice if you wish to submit a claim independently.
ChondroFiller is suited to patients with cartilage wear across the spectrum, from a contained focal defect to diffuse surface wear across the joint, in the knee, hip, shoulder, ankle, elbow, foot, hand or wrist. There is no upper age limit and no defect-size limit on the injection. It is particularly valuable as a pre-replacement option for active patients in their 60s, 70s and beyond who want to preserve their own joint. Suitability is confirmed by Professor Lee at consultation after imaging review. Take the ChondroFiller suitability self-assessment for a quick indicator.
ChondroFiller is a regenerative scaffold, not an immediate pain-relief injection. Most patients begin to notice improvement at six to twelve weeks, with continued benefit building over six to twelve months as new tissue establishes within the scaffold. The aim is to support natural cartilage regeneration and preserve the joint, not to mask symptoms.
ChondroFiller is delivered as a 30 to 45 minute outpatient injection under ultrasound guidance, with no general anaesthetic and no surgical incision. The gel sets within minutes inside the cartilage defect. Patients walk out the same hour with no brace or crutches (unless the medical team specifies otherwise), keep the first three days quiet, then build back from about half their usual joint activity in weeks one and two to normal by week six. Onward physiotherapy is optional, quoted separately. Read the injection recovery guide for the full aftercare, including why it differs from surgical ChondroFiller.